Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K.G. Brodovicz
Empagliflozin Selected Cardiovascular and Safety Outcomes in Routine Care: First Results From the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) Study
Metabolism: Clinical and Experimental
Endocrinology
Metabolism
Diabetes
Pss10 - Quantitative Analysis of Diabetic Retinopathy (Dr) in the Uk Using Routinely Collected Data From Screening Programme and Hospital Eye Service (Hes) Databases
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pdb15 - Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors: Systematic Literature Review and Indirect Comparisons
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pdb12 - Cardiovascular Safety of Empagliflozin Versus Glucagon-Like Peptide-1 (Glp-1) Receptor Agonists: Systematic Literature Review and Indirect Comparisons
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pdb76 - Cost-Effectiveness Analysis of Empagliflozin in Comparison to Liraglutide Based on Cardiovascular Outcome Trials
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Ce1 - Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Empagliflozin/Linagliptin Single-Tablet Combination: First-In-Class Treatment Option
International Journal of Clinical Practice
Medicine
TAS-102 Safety in Metastatic Colorectal Cancer: Results From the First Postmarketing Surveillance Study
Clinical Colorectal Cancer
Oncology
Gastroenterology
Empagliflozin in Type 1 Diabetes
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Empagliflozin, a Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor, in Healthy Japanese Subjects
Drug Metabolism and Pharmacokinetics
Pharmacology
Pharmaceutical Science
Diabetische Ketoazidose Unter Empagliflozin
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
